MAGGI, MARISTELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.497
AS - Asia 930
EU - Europa 705
SA - Sud America 149
Continente sconosciuto - Info sul continente non disponibili 58
AF - Africa 55
OC - Oceania 4
Totale 3.398
Nazione #
US - Stati Uniti d'America 1.453
CN - Cina 391
SG - Singapore 211
IE - Irlanda 184
HK - Hong Kong 117
BR - Brasile 110
RU - Federazione Russa 108
VN - Vietnam 99
IT - Italia 97
DE - Germania 84
FI - Finlandia 79
FR - Francia 38
ZA - Sudafrica 34
IN - India 30
CA - Canada 26
GB - Regno Unito 26
SE - Svezia 20
UA - Ucraina 16
BE - Belgio 14
AR - Argentina 13
ID - Indonesia 12
MX - Messico 12
JP - Giappone 11
PK - Pakistan 9
BD - Bangladesh 8
EC - Ecuador 8
IQ - Iraq 8
PL - Polonia 8
MY - Malesia 6
TR - Turchia 6
CL - Cile 5
EG - Egitto 5
ES - Italia 5
MA - Marocco 5
NL - Olanda 5
SA - Arabia Saudita 5
AT - Austria 4
CO - Colombia 4
ET - Etiopia 4
IL - Israele 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
VE - Venezuela 3
LT - Lituania 2
LV - Lettonia 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
CH - Svizzera 1
DZ - Algeria 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PW - Palau 1
RO - Romania 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
ZM - Zambia 1
Totale 3.340
Città #
Chandler 187
Dublin 184
Ashburn 163
San Jose 147
Singapore 129
Hong Kong 115
Beijing 106
Dallas 87
Council Bluffs 74
Nanjing 64
Ann Arbor 49
Los Angeles 43
Helsinki 41
Jacksonville 38
Munich 38
Boardman 37
Ho Chi Minh City 36
New York 36
Johannesburg 33
Lauterbourg 27
Lawrence 25
Medford 25
Princeton 25
Wilmington 24
Moscow 20
Turku 18
Buffalo 17
Changsha 17
Hanoi 17
Santa Clara 16
Shanghai 15
Milan 14
São Paulo 14
Brussels 13
Jiaxing 13
Shenyang 13
Pavia 11
Tokyo 11
Denver 10
Nanchang 10
London 9
Tianjin 9
Toronto 9
Atlanta 8
Chicago 8
Florence 8
Redondo Beach 8
Seattle 8
Warsaw 8
Columbus 7
Dearborn 7
Frankfurt am Main 7
Nuremberg 7
Orem 7
The Dalles 7
Boston 6
Chongqing 6
Fairfield 6
Hebei 6
Washington 6
Falkenstein 5
Guangzhou 5
Hangzhou 5
Houston 5
Lahore 5
Montreal 5
Monza 5
Pune 5
Addis Ababa 4
Brooklyn 4
Calgary 4
Da Nang 4
Haiphong 4
Naples 4
Phoenix 4
Redwood City 4
San Francisco 4
Shenzhen 4
Stockholm 4
Travaco Siccomario 4
Bến Tre 3
Cairo 3
Campinas 3
Curitiba 3
Delhi 3
Dhaka 3
Edinburgh 3
Fayetteville 3
Fuzhou 3
Hải Dương 3
Jinan 3
Mexico City 3
Miami 3
Modena 3
Parma 3
Piemonte 3
Riyadh 3
Tel Aviv 3
Woodbridge 3
Amsterdam 2
Totale 2.256
Nome #
An antibody drug conjugate based on asparaginase 173
A targeted catalytic nanobody (T-can) with asparaginolytic activity 151
Anti-cancer auto-antibodies: Roles, applications and open issues 144
Generation of Mutants of Helicobacter pylori L-Asparaginase 139
Engineering of Helicobacter pylori L-asparaginase: characterization of two functionally distinct groups of mutants 138
Biochemistry of Lipolytic Enzymes Secreted by Penicillium solitum and Cladosporium cladosporioides 137
A new mutation of the pgk1 gene detected in an italian patient affected by phosphoglycerate kinase deficiency. 129
Expanding Targets for a Metabolic Therapy of Cancer: L- Asparaginase 127
Glutaminase activity determines cytotoxicity of l-asparaginases on most leukemia cell lines 126
Clinical Severity of PGK1 Deficiency Due To a Novel p.E120K Substitution Is Exacerbated by Co-inheritance of a Subclinical Translocation t(3;14)(q26.33;q12), Disrupting NUBPL Gene. 126
A HIGHLY STABLE, PROTEASE-RESISTANT E. COLI ASPARAGINASE 125
A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro 122
Enzymes in metabolic anticancer therapy 121
Targeted single domain antibodies with catalytic activity (T-CAN) 119
A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization. 114
Data on enhanced expression and purification of camelid single domain antibodies from Escherichia coli classical inclusion bodies 111
High Resolution Structure of Human Apolipoprotein (a) Kringle IV Type 2: Beyond the Lysine Binding Site 104
Differential effect of asparagine and glutamine removal on three adenocarcinoma cell lines 101
Asparagine and Glutamine Deprivation Alters Ionizing Radiation Response, Migration and Adhesion of a p53null Colorectal Cancer Cell Line 98
HAP1 loss in L-asparaginase resistance 97
In Vitro Evaluation of the Biological Availability of Hyaluronic Acid Polyethylene Glycols-Cross-Linked Hydrogels to Bovine Testes Hyaluronidase 95
Enhanced expression and purification of camelid single domain VHH antibodies from classical inclusion bodies. 92
Helicobacter pylori L-asparaginase: A Novel Bacterial Antigen that May Contribute to Infection Detection 83
Glutaminase activity determines cytotoxicity of L-asparaginases on leukemia cell lines 82
Revealing Escherichia coli type II l-asparaginase active site flexible loop in its open, ligand-free conformation 81
Tackling Critical Catalytic Residues in Helicobacter pylori L-Asparaginase 80
Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets 65
The phosphoglycerate kinase 1 variants found in carcinoma cells display different catalytic activity and conformational stability compared to the native enzyme 64
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 54
Insights into human phosphoglycerate kinase 1 deficiency as a conformational disease from biochemical, biophysical, and in vitro expression analyses 53
Structural Aspects of E. coli Type II Asparaginase in Complex with Its Secondary Product L-Glutamate 48
Protein stability, folding and misfolding in human PGK1 deficiency 37
Selection of Functional Glycoforms in Anti-SARS-CoV-2 Human IgG1 Monoclonal Antibodies by FcγRIIIa Affinity Chromatography and Mass Spectrometry 25
Emerging Protein Targets in Triple-Negative Breast Cancer: Beyond Conventional Therapy 21
SerpinB3/Protease Activated Receptor-2 Axis Is Essential for SARS CoV-2 Infection 16
Totale 3.398
Categoria #
all - tutte 15.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 0 0 7 7 6 5 7 10 5 21 65
2022/2023501 43 50 2 65 39 40 0 19 218 2 17 6
2023/2024247 28 41 5 16 21 62 9 42 2 8 3 10
2024/2025630 7 48 15 12 40 49 51 27 156 18 67 140
2025/20261.286 97 88 159 163 141 44 197 68 147 105 42 35
2026/2027219 14 71 105 29 0 0 0 0 0 0 0 0
Totale 3.398